KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Operating Income (2018 - 2026)

ClearPoint Neuro's Operating Income history spans 13 years, with the latest figure at -$7.0 million for Q4 2025.

  • On a quarterly basis, Operating Income fell 169.71% to -$7.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$24.2 million, a 505.31% decrease, with the full-year FY2025 number at -$24.2 million, down 505.31% from a year prior.
  • Operating Income hit -$7.0 million in Q4 2025 for ClearPoint Neuro, down from -$5.3 million in the prior quarter.
  • Over the last five years, Operating Income for CLPT hit a ceiling of $10.1 million in Q4 2024 and a floor of -$7.1 million in Q2 2023.
  • Historically, Operating Income has averaged -$4.0 million across 5 years, with a median of -$4.6 million in 2022.
  • Biggest five-year swings in Operating Income: crashed 199.06% in 2021 and later skyrocketed 314.75% in 2024.
  • Tracing CLPT's Operating Income over 5 years: stood at -$4.0 million in 2021, then decreased by 12.23% to -$4.5 million in 2022, then decreased by 5.3% to -$4.7 million in 2023, then skyrocketed by 314.75% to $10.1 million in 2024, then plummeted by 169.71% to -$7.0 million in 2025.
  • Business Quant data shows Operating Income for CLPT at -$7.0 million in Q4 2025, -$5.3 million in Q3 2025, and -$5.7 million in Q2 2025.